Fibromyalgia & musculoskeletal pain
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)
An erratum to this article was published (J Rheumatol, 1 Jul 2024 ↗)
Authors' conclusion
Participants with FM identify a variety of symptoms that significantly affect their daily lives. Many of these symptoms, such as fatigue, sleep disturbance, and activity limitation, are life-altering and not related to traditional diagnostic criteria. Symptom prevalence in this population varies across subgroups based on demographic categories and disability status.
Study context
- Population
- Adults with fibromyalgia (FM)plus 15 interviewed
- Participants
- 1,085 adults
- Outcome
- Prevalence and relative importance (scale 0-4) of 149 symptoms representing 14 symptomatic themes
Methodological detailsinternational, semistructured interviews (qualitative phase), subgroup analysis
- International
- Semistructured interviews (qualitative phase)
- Subgroup analysis
Main finding
As reported in the abstract
- Prevalence: pain
- 99.8%
- Prevalence: muscle tenderness
- 99.8%
- Prevalence: fatigue
- 99.3%
- Effect on life: fatigue
- 2.88
- Effect on life: pain
- 2.85
- Effect on life: muscle tenderness
- 2.79
- Effect on life: impaired sleep and daytime sleepiness
- 2.70
Observational data: associations, not effects.
Further findings
Factors associated with symptomatic theme prevalence (subgroups)
- Most strongly associated with modified Rankin Scale level of disability, disability status, and change in employment status (on disability vs not on disability)
Original publication
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM). J Rheumatol. Published 15 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →